Prognostic model for traumatic death due to bleeding: cross-sectional international study. (2019)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-026823
PubMed Identifier: 31142526
Publication URI: http://europepmc.org/abstract/MED/31142526
Type: Journal Article/Review
Volume: 9
Parent Publication: BMJ open
Issue: 5
ISSN: 2044-6055